nach oben

Erschienen in:

01.05.2014 | Article

Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults

verfasst von: Anna Viitasalo, Timo A. Lakka, David E. Laaksonen, Kai Savonen, Hanna-Maaria Lakka, Maija Hassinen, Pirjo Komulainen, Tuomo Tompuri, Sudhir Kurl, Jari A. Laukkanen, Rainer Rauramaa

Erschienen in: Diabetologia | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We validated the metabolic syndrome (MetS) score by confirmatory factor analysis (CFA) in children, middle-aged men, and older women and men and by investigating the relationships of the MetS score to incident type 2 diabetes, myocardial infarction, and cardiovascular and overall death in middle-aged men.

Methods

We assessed the core features of MetS, calculated the MetS score using z scores for waist circumference, insulin, glucose, triacylglycerols, HDL-cholesterol and blood pressure, and carried out CFA to investigate whether MetS represents a single entity in population samples of 491 children, 1,900 middle-aged men, 614 older women and 555 older men from Finland. We also followed-up incident type 2 diabetes for 11 years and other outcomes for 17–18 years in middle-aged men.

Results

We carried out second-order CFAs in which the MetS was represented by a second-order latent variable underlying four latent variables characterised by abdominal obesity, insulin resistance, dyslipidaemia and raised blood pressure in different age groups. These second-order factors and factors derived from first-order CFA using previously proposed models were strongly associated with a composite MetS score in all age groups (r = 0.84–0.94) and similarly predicted type 2 diabetes, cardiovascular outcomes and mortality in middle-aged men. The risk of type 2 diabetes, myocardial infarction, cardiovascular death and overall death increased 3.67-, 1.38-, 1.56- and 1.44-fold, respectively, for a 1 SD increase in the MetS score.

Conclusions

The MetS can be described as a single entity in all age groups. The MetS score is a valid tool for research evaluating cardiometabolic risk in different age groups. Further research is needed to define cut-off points for risk estimation in clinical practice.

Nur mit Berechtigung zugänglich

Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef

Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011) Metabolic syndrome: definitions and controversies. BMC Med 9:48PubMedCentralPubMedCrossRef

Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28:629–636PubMedCrossRef

Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497

Morrison JA, Friedman LA, Gray-McGuire C (2007) Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 120:340–345PubMedCrossRef

Morrison JA, Friedman LA, Wang P, Glueck CJ (2008) Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 152:201–206PubMedCrossRef

Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077PubMedCrossRef

McNeill AM, Rosamond WD, Girman CJ et al (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28:385–390PubMedCrossRef

Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716PubMedCrossRef

10.

Brambilla P, Lissau I, Flodmark CE et al (2007) Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes (Lond) 31:591–600CrossRef

11.

Steinberger J, Daniels SR, Eckel RH et al (2009) Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119:628–647PubMedCrossRef

12.

Andersen LB, Harro M, Sardinha LB et al (2006) Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet 368:299–304PubMedCrossRef

13.

Eisenmann JC, Laurson KR, DuBose KD, Smith BK, Donnelly JE (2010) Construct validity of a continuous metabolic syndrome score in children. Diabetol Metab Syndr 2:8PubMedCentralPubMedCrossRef

14.

Pandit D, Chiplonkar S, Khadilkar A, Kinare A, Khadilkar V (2011) Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk. Int J Obes (Lond) 35:1318–1324CrossRef

15.

Hanley AJ, Karter AJ, Festa A et al (2002) Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 51:2642–2647PubMedCrossRef

16.

Martinez-Vizcaino V, Martinez MS, Aguilar FS et al (2010) Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care 33:1370–1372PubMedCentralPubMedCrossRef

17.

Child D (1990) The essentials of factor analysis. Cassell, London

18.

Li C, Ford ES (2007) Is there a single underlying factor for the metabolic syndrome in adolescents? A confirmatory factor analysis. Diabetes Care 30:1556–1561PubMedCrossRef

19.

Shen BJ, Todaro JF, Niaura R et al (2003) Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 157:701–711PubMedCrossRef

20.

Pladevall M, Singal B, Williams LK et al (2006) A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 29:113–122PubMedCrossRef

21.

Hillier TA, Rousseau A, Lange C et al (2006) Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia 49:1528–1535PubMedCentralPubMedCrossRef

22.

Viitasalo A, Laaksonen DE, Lindi V et al (2012) Clustering of metabolic risk factors is associated with high-normal levels of liver enzymes among 6- to 8-year-old children: the PANIC Study. Metab Syndr Relat Disord 10:337–343PubMedCrossRef

23.

Hassinen M, Lakka TA, Savonen K et al (2008) Cardiorespiratory fitness as a feature of metabolic syndrome in older men and women: the Dose-Responses to Exercise Training Study (DR's EXTRA). Diabetes Care 31:1242–1247PubMedCrossRef

24.

Ekelund U, Anderssen SA, Froberg K et al (2007) Independent associations of physical activity and cardiorespiratory fitness with metabolic risk factors in children: the European Youth Heart Study. Diabetologia 50:1832–1840PubMedCrossRef

25.

Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48:1684–1699PubMedCrossRef

26.

Wijndaele K, Beunen G, Duvigneaud N et al (2006) A continuous metabolic syndrome risk score: utility for epidemiological analyses. Diabetes Care 29:2329PubMedCrossRef

27.

Eisenmann JC (2008) On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 7:17PubMedCentralPubMedCrossRef

28.

Meigs JB (2000) Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152:908–911, discussion 912PubMedCrossRef

29.

Laaksonen DE, Niskanen L, Lakka HM, Lakka TA, Uusitupa M (2004) Epidemiology and treatment of the metabolic syndrome. Ann Med 36:332–346PubMedCrossRef

30.

Martinez-Vizcaino V, Ortega FB, Solera-Martinez M et al (2011) Stability of the factorial structure of metabolic syndrome from childhood to adolescence: a 6-year follow-up study. Cardiovasc Diabetol 10:81PubMedCentralPubMedCrossRef

31.

Povel C, Beulens J, van der Schouw Y et al (2012) Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease. Diabetes Care 36:362–368PubMedCrossRef

32.

Siegel MJ, Hildebolt CF, Bae KT, Hong C, White NH (2007) Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology 242:846–856PubMedCrossRef

33.

Benfield LL, Fox KR, Peters DM et al (2008) Magnetic resonance imaging of abdominal adiposity in a large cohort of British children. Int J Obes (Lond) 32:91–99CrossRef

34.

Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243PubMedCentralPubMedCrossRef

35.

Cornier MA, Dabelea D, Hernandez TL et al (2008) The metabolic syndrome. Endocr Rev 29:777–822PubMedCrossRef

36.

Widhalm K, Ghods E (2010) Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes (Lond) 34:1451–1467CrossRef

37.

Bennett B, Larson-Meyer DE, Ravussin E et al (2011) Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity (Silver Spring) 20:371–375CrossRef

Titel: Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults
verfasst von: Anna Viitasalo
Timo A. Lakka
David E. Laaksonen
Kai Savonen
Hanna-Maaria Lakka
Maija Hassinen
Pirjo Komulainen
Tuomo Tompuri
Sudhir Kurl
Jari A. Laukkanen
Rainer Rauramaa
Publikationsdatum: 01.05.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 5/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-014-3172-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment

Erratum to: Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model

Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects

Pancreatic duct cells as a source of VEGF in mice

Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment